| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/29/2005 | US20050214218 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 09/29/2005 | US20050214212 Antibodies specific for CD44v6 |
| 09/29/2005 | US20050214211 Active and/or passive immunization; accurate early stage, localized tumor detection |
| 09/29/2005 | US20050214210 Antibodies that immunospecifically bind to TRAIL receptors |
| 09/29/2005 | US20050214209 Anitcancer and antiproliferative agents; tumor necrosis factor related apoptosis inducing ligand (TRAIL); combination of amino acid sequences from VHCDR1, 2 or 3 with VLCDR1, 2 or 3 of sequence numbers 42 through 53; isolated cells; kits |
| 09/29/2005 | US20050214208 Anitcancer and antiproliferative agents; tumor necrosis factor related apoptosis inducing ligand (TRAIL); combination of amino acid sequences from VHCDR1, 2 or 3 with VLCDR1, 2 or 3 of sequence numbers 42 through 56; isolated cells; kits |
| 09/29/2005 | US20050214207 Antibodies that immunospecifically bind toTRAIL receptors |
| 09/29/2005 | US20050214206 Antibodies that immunospecifically bind to TRAIL receptors |
| 09/29/2005 | US20050214205 Antibodies that immunospecifically bind to TRAIL receptors |
| 09/29/2005 | CA2598879A1 Prostate stem cell |
| 09/29/2005 | CA2562133A1 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
| 09/29/2005 | CA2560953A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 09/29/2005 | CA2560305A1 Human anti-epidermal growth factor receptor antibody |
| 09/29/2005 | CA2559840A1 Prostatic acid phosphatase antigens |
| 09/29/2005 | CA2559658A1 Antibody calicheamicin conjugates |
| 09/29/2005 | CA2559554A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/29/2005 | CA2559280A1 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 09/29/2005 | CA2559215A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 09/29/2005 | CA2559211A1 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 09/29/2005 | CA2558737A1 Antibody calicheamicin conjugates for passive targeting |
| 09/29/2005 | CA2558371A1 Methods of modulating immune responses by modulating tim-1 and tim-4 function |
| 09/29/2005 | CA2557866A1 Calicheamicin conjugation by antibody deglycosylation |
| 09/29/2005 | CA2556080A1 Novel tat complexes, and vaccines comprising them |
| 09/29/2005 | CA2546157A1 Improved expression systems with sec-system secretion |
| 09/28/2005 | EP1580553A1 Method of assaying elastin digestion product and assay kit, method of detecting aortic dissection and detection kit |
| 09/28/2005 | EP1580282A1 Use of human RPS6KA6-related gene variant for diagnosing T cell lymphoblastic lymphoma |
| 09/28/2005 | EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof |
| 09/28/2005 | EP1579863A2 Combination therapy with anti-gastrin G17 antibodies for the treatment of tumors |
| 09/28/2005 | EP1579222A1 Non-competitive immunoassay for small analytes |
| 09/28/2005 | EP1579218A2 Method of modulation of interaction between receptor and ligand |
| 09/28/2005 | EP1579214A2 Methods of screening for anti-inflammatory drugs and use thereof |
| 09/28/2005 | EP1579213A1 Method of diagnosis,treatment and useful agents for conditions characterised by modulation in the level of activin beta c. |
| 09/28/2005 | EP1578989A2 Novel nucleic acids and secreted polypeptides |
| 09/28/2005 | EP1578987A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 09/28/2005 | EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof |
| 09/28/2005 | EP1578980A2 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
| 09/28/2005 | EP1578962A2 Carrier-ligand fusions and uses thereof |
| 09/28/2005 | EP1578955A2 Candida kefyr cytosine deaminase |
| 09/28/2005 | EP1578947A2 Antibodies directed to phospholipase a2 and uses thereof |
| 09/28/2005 | EP1578936A2 Human anti-ifn-gamma neutralizing antibodies as selective ifn-gamma pathway inhibitors |
| 09/28/2005 | EP1578929A2 Nematode phosphoethanolamine n-methyltransferase-like sequences |
| 09/28/2005 | EP1578923A2 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions |
| 09/28/2005 | EP1578922A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 09/28/2005 | EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer |
| 09/28/2005 | EP1578917A2 Multimeric proteins and methods of making and using same |
| 09/28/2005 | EP1578914A2 Human ion channels |
| 09/28/2005 | EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/28/2005 | EP1578911A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 09/28/2005 | EP1578910A2 Nitrilases |
| 09/28/2005 | EP1578907A2 Secreted protein, ztnf9 |
| 09/28/2005 | EP1578906A2 Afap sequences, polypeptides, antibodies and methods |
| 09/28/2005 | EP1578903A2 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| 09/28/2005 | EP1578902A2 Neurotransmission-associated proteins |
| 09/28/2005 | EP1578899A2 Secreted proteins |
| 09/28/2005 | EP1578801A2 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
| 09/28/2005 | EP1578800A2 Antibodies lacking vacuolar targeting signal peptide and capable of binding j-chain |
| 09/28/2005 | EP1578799A2 Antibodies directed to tumor necrosis factor and uses thereof |
| 09/28/2005 | EP1578783A2 Target recognizing binding agents |
| 09/28/2005 | EP1578782A2 Combination therapy with co-stimulatory factors |
| 09/28/2005 | EP1578779A2 Erythropoietin receptor binding antibodies |
| 09/28/2005 | EP1578776A2 Products for regulating the degradation of collagen and methods for indentifying same |
| 09/28/2005 | EP1578774A2 Protein purification |
| 09/28/2005 | EP1578772A2 Cytokines and cytokine receptors with reduced immunogenicity |
| 09/28/2005 | EP1578771A2 Remodeling and glycoconjugation of peptides |
| 09/28/2005 | EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/28/2005 | EP1578461A2 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 09/28/2005 | EP1578447A2 Methods and compositions for increasing antibody production |
| 09/28/2005 | EP1578446A2 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 09/28/2005 | EP1578445A2 Therapeutic adjuvant |
| 09/28/2005 | EP1578444A2 Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis |
| 09/28/2005 | EP1578439A2 Low dose methods for treating disorders in which tnf-alpha activity is detrimental |
| 09/28/2005 | EP1578397A2 Human monoclonal antibodies against cd25 |
| 09/28/2005 | EP1578385A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 09/28/2005 | EP1578380A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 09/28/2005 | EP1578374A2 Escape mutants of newcastle disease virus as marker vaccines |
| 09/28/2005 | EP1578372A2 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 09/28/2005 | EP1578371A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/28/2005 | EP1578368A2 Compositions and methods for the treatment of rheumatoid arthritis |
| 09/28/2005 | EP1578367A2 Compositions and methods for the treatment of immune related diseases |
| 09/28/2005 | EP1578364A2 Compositions and methods for the treatmentof immune related diseases |
| 09/28/2005 | EP1578361A2 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 09/28/2005 | EP1578358A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 09/28/2005 | EP1578347A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/28/2005 | EP1578345A2 Peptides and antibodies to muc 1 proteins |
| 09/28/2005 | EP1578305A2 Canine rankl and methods for preparing and using the same |
| 09/28/2005 | EP1578254A2 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 09/28/2005 | EP1578205A2 Biomarkers for intro-aminiotic inflammation |
| 09/28/2005 | EP1578197A2 Composition and method for treating lupus nephritis |
| 09/28/2005 | EP1534404A4 Use of a clathrate modifier to promote passage of proteins during nanofiltration |
| 09/28/2005 | EP1465489A4 Methods of expressing lim mineralization protein in non-osseous cells |
| 09/28/2005 | EP1402261A4 Colon cancer antigen panel |
| 09/28/2005 | EP1267905B1 Composition for the treatment of heart failure |
| 09/28/2005 | EP1263787B1 G-protein coupled receptor |
| 09/28/2005 | EP1137766B1 Use of il-12 antibodies to treat psoriasis |
| 09/28/2005 | EP1037991B1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 09/28/2005 | CN1675357A Pramyxovirus vectors encoding antibody and utilization thereof |
| 09/28/2005 | CN1675355A Novel lipases and uses thereof |
| 09/28/2005 | CN1675246A Protein for diagnosing diabetic retinopathy |
| 09/28/2005 | CN1675245A Monoclonal antibody hPAM4 |
| 09/28/2005 | CN1675244A MCAM inhibitors |